Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.

被引:0
|
作者
Iacono, Donatella
Vitale, Maria Grazia
Cortiula, Francesco
Macerelli, Marianna
Cinausero, Marika
Minisini, Alessandro Marco
Valent, Francesca
Tullio, Annarita
Palmero, Lorenza
Targato, Giada
Zara, Diego
Fasola, Gianpiero
机构
[1] Univ Hosp Udine, Dept Oncol, Udine, Italy
[2] Univ Udine, Dept Med DAME, Udine, Italy
[3] Azienda Sanit Univ Integrata Udine, Dipartimento Oncol, Udine, Italy
[4] Univ Hosp Udine, Inst Hyg & Clin Epidemiol, Udine, Italy
[5] Univ Udine, Udine, Italy
[6] Univ Hosp Udine Santa Maria della Misericordia, Dept Oncol, Udine, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15163
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Real-world effectiveness and drug survival of dupilumab: A single-center retrospective analysis
    Brazil, Molly
    Topham, Christina
    Simpson, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB123 - AB123
  • [32] Evaluating immune-related adverse events (irAEs) in a real-world cohort with lung cancer receiving immunotherapy
    Hu, Xiao
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Parsons, Susan K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E32
  • [33] A single center experience with neuromuscular immune-related adverse events of immune checkpoint inhibitors
    Moreno Lopez, C.
    Chico Garcia, J.
    Martinez Garcia, B.
    Garcia Alcantara, G.
    Lopez Rebolledo, R.
    Cabanas Engenios, G.
    Corral Corral, I.
    Alvarez Velasco, R.
    Buisan Catevilla, F.
    Garcia Barragan, N.
    Zarza Sanz, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 468 - 468
  • [34] Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study
    Moldovianu, Ana-Maria
    Stoia, Razvan
    Vasilica, Mariana
    Ursuleac, Iulia
    Badelita, Sorina Nicoleta
    Tomescu, Andra Alina
    Preda, Oana Diana
    Bardas, Alexandru
    Cirstea, Mihaela
    Coriu, Daniel
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [35] Immunotherapy - immune-related adverse events and their management
    Petrausch, Ulf
    THERAPEUTISCHE UMSCHAU, 2019, 76 (04) : 195 - 198
  • [36] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [37] Immune-related adrenal insufficiency: A single center retrospective analysis
    Polshina, Natalya
    Filonenko, Daria
    Volkova, Ekaterina
    Zhukova, Lyudmila
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Patterns and risk factors of immune-related adverse events in a real-world cohort with lung cancer receiving immunotherapy
    Hu, Xiao
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana
    Lin, Jeffrey
    Parsons, Susan K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Immune checkpoint inhibitor-related adverse events: Real-world experience from a single veterans' affairs medical center
    Benz, Samantha
    Sherman, Katherine A.
    Dasanu, Constantin A.
    Alvarez-Argote, Juliana
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (04) : 697 - 704
  • [40] Real-World Characterization of Immune-Related Adverse Events in Nova Scotia Patients Treated with Pembrolizumab or Durvalumab and Adherence to Toxicity Management Guidelines
    Bowles, S.
    Daniels, A.
    DiCostanzo, T.
    Minard, L.
    Scott, S.
    Snow, S.
    Teimouri, A.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2024, 77 (02):